Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Handa PharmaceuticalsROCO:6620 +9.69%86 Dividend Payout Ratio is 10.92 as of Jun. 2026, which is 3423% above its 10-year median of 0.31. GuruFocus rates ROCO:6620 with a GF Score™ of 86/100 and a GF Value™ of NT$109.77 (Fairly Valued). The stock has 4 warning signs investors should review. Among 447 Drug Manufacturers companies, Handa Pharmaceuticals ranks worse than 77.4% on this metric.
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period. Handa Pharmaceuticals's Dividend Payout Ratio for the
months ended in Jun. 2026 was 10.92.
The historical rank and industry rank for Handa Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:
ROCO:6620'
s Dividend Payout Ratio Range Over the Past 10 Years
Min: 0.3 Med: 0.31 Max: 0.68
Current: 0.68
During the past 12 years, the highest Dividend Payout Ratio of Handa Pharmaceuticals was 0.68. The lowest was 0.30. And the median was 0.31.
ROCO:6620's Dividend Payout Ratio is ranked worse than 77.4% of 447
companies
in the Drug Manufacturers industry
Industry Median: 0.38
vs ROCO:6620: 0.68
During the past 12 years, the highest Trailing Annual Dividend Yield of Handa Pharmaceuticals was 2.77%. The lowest was 0.94%. And the median was 1.53%.
Handa Pharmaceuticals (ROCO:6620) Dividend Payout Ratio Explanation
In dividends investing, Dividend Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Handa Pharmaceuticals Dividend Payout Ratio Related Terms
Handa Pharmaceuticals Dividend Payout Ratio Historical Data
* Premium members only.
The historical data trend for Handa Pharmaceuticals's Dividend Payout Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6620 vs ZTS: Dividend Payout Ratio Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Handa Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Handa Pharmaceuticals Dividend Payout Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Handa Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:
* The bar in red indicates where Handa Pharmaceuticals's Dividend Payout Ratio falls into.
Handa Pharmaceuticals Dividend Payout Ratio Calculation
The Dividend Payout Ratio is the measure of dividends paid out to shareholders relative to the company's net income. It is calculated as the Dividends per Share divided by the Earnings per Share (Diluted) during the same time period.
Handa Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Handa Pharmaceuticals (ROCO:6620) has a Dividend Payout Ratio of 10.92 as of Jun. 2026. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Handa Pharmaceuticals and its competitors. This is 3423% above median its historical median of 0.31. Over the past decade, Handa Pharmaceuticals' Dividend Payout Ratio has ranged from 0.30 to 0.68. According to the industry distribution chart, Handa Pharmaceuticals ranks #346 out of 447 companies in the Drug Manufacturers industry, placing it in the top 77.4%.
Is Handa Pharmaceuticals' Dividend Payout Ratio too high?
Handa Pharmaceuticals' current Dividend Payout Ratio of 10.92 is 3423% above median its 10-year median of 0.31. Over the past 10 years, this metric has ranged from a low of 0.30 to a high of 0.68. The Drug Manufacturers industry median Dividend Payout Ratio is 0.38. Handa Pharmaceuticals' value of 10.92 is 2773.7% above this industry median. Based on the distribution chart, Handa Pharmaceuticals ranks #346 out of 447 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Handa Pharmaceuticals has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Handa Pharmaceuticals' Dividend Payout Ratio compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Handa Pharmaceuticals ranks #346 out of 447 companies for Dividend Payout Ratio. This places Handa Pharmaceuticals in the lower half of its industry. The industry median Dividend Payout Ratio is 0.38. Handa Pharmaceuticals' value of 10.92 is 2773.7% above this benchmark. Historically, Handa Pharmaceuticals' own Dividend Payout Ratio has ranged from 0.30 to 0.68 over the past decade. While the company's 10-year median is 0.31 vs. the industry median of 0.38, Handa Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Payout Ratio for a Drug Manufacturers company?
The median Dividend Payout Ratio among Drug Manufacturers companies is 0.38, based on 447 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Payout Ratio significantly above this median, while those in the bottom quartile fall well below. However, Dividend Payout Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Handa Pharmaceuticals's current Dividend Payout Ratio of 10.92 is 2773.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Payout Ratio mean?
A high Dividend Payout Ratio can signal that a stock is expensive relative to its fundamentals. Dividend payout ratio is the percent of company earnings paid out as dividends. View historical data on Handa Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Dividend Payout Ratio is 0.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Handa Pharmaceuticals's current Dividend Payout Ratio is 10.92, which is 3423% above median its own 10-year median of 0.31. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Handa Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Handa Pharmaceuticals (ROCO:6620) is currently considered Fairly Valued. The stock's GF Value™ is NT$109.77, compared to a current price of NT$107.50 — trading 2.1% below its estimated fair value. The current Dividend Payout Ratio is 10.92, which is 3423% above median its 10-year median of 0.31 and 2773.7% above the Drug Manufacturers industry median of 0.38. Handa Pharmaceuticals' overall GF Score™ is 86/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Payout Ratio calculated?
Dividend Payout Ratio is calculated from a company's financial statements. For Handa Pharmaceuticals (ROCO:6620), the current Dividend Payout Ratio is 10.92 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Handa Pharmaceuticals (ROCO:6620) Overvalued in 2026?
Based on GuruFocus' analysis, Handa Pharmaceuticals stock appears to be undervalued.
The current stock price of NT$107.50 is trading 2.1% below its estimated GF Value™ of NT$109.77.
GuruFocus considers Handa Pharmaceuticals to be Fairly Valued.
Key valuation signals for ROCO:6620:
Dividend Payout Ratio: 10.92 (3423% above median its 10-year median of 0.31)
GF Value™: NT$109.77 vs. price of NT$107.50 (2.1% below fair value)
Industry Position: 2773.7% above the Drug Manufacturers median (#346 of 447)
No single metric tells the full story. See the ROCO:6620 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Handa Pharmaceuticals Inc is a Taiwan-based specialty pharmaceutical company. It is engaged in the development of niche drugs. The company focuses on the development of high-barrier/patentable niche products.
86GF Score
Get the complete analysis for ROCO:6620
Dividend Payout Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6620 has been successfully added to your 
